Rite Aid (RAD, $1.28) Wants A Board Reshuffle
Rite Aid wants to rejig its board, after two failed merger plans.
The drugstore chain said Thursday that three new, independent directors will be nominated to its board and that CEO John Standley will no longer hold the title of chairman. Next month, shareholders will vote on whether to approve board nominees Robert Knowling Jr., Louis Miramontes and Arun Nayar – who, if elected, would replace current directors David Jessick, Myrtle Potter and Frank Savage. The shakedown of management comes close on the heels of failure of two buyout attempts - by the grocer Albertsons and pharmacy chain Walgreens respectively.
Walgreens, however, did buy nearly 2,000 stores from Rite Aid Corp. Following the sale of its stores, Rite Aid now has about 2,500 locations mostly on the East and West coasts, and a pharmacy benefit management business.
On Thursday, Rite Aid announced that its fiscal second-quarter earnings narrowly fell short of the consensus expectation on Wall Street.
WBA's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for WBA turned positive on April 23, 2025. Looking at past instances where WBA's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on WBA as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
WBA moved above its 50-day moving average on May 07, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for WBA crossed bullishly above the 50-day moving average on May 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WBA advanced for three days, in of 253 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WBA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
WBA broke above its upper Bollinger Band on May 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for WBA entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.250) is normal, around the industry mean (3.463). P/E Ratio (32.848) is within average values for comparable stocks, (181.246). Projected Growth (PEG Ratio) (2.170) is also within normal values, averaging (1.915). Dividend Yield (0.086) settles around the average of (0.050) among similar stocks. P/S Ratio (0.117) is also within normal values, averaging (0.903).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. WBA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WBA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a provider of drug store services
Industry DrugstoreChains